相似文献/References:
[1]谭思敏 李瑞庄 黎宗汉 方林彬.原发性青光眼滤过术后发生恶性青光眼的危险因素分析[J].眼科新进展,2013,33(12):000.
[2]肖情,冯光强.microRNA对原发性青光眼TGF-β和CYP1B1基因调控的研究进展[J].眼科新进展,2014,34(5):497.[doi:10.13389/j.cnki.rao.2014.0137]
XIAO Qing,FENG Guang-Qiang.Recent advances in MiRNA regulating TGF-β and CYP1B1 gene in primary glaucoma[J].Recent Advances in Ophthalmology,2014,34(11):497.[doi:10.13389/j.cnki.rao.2014.0137]
[3]黄倞,刘琳琳,罗耀玲,等. 原发性青光眼合并2型糖尿病患者房水及血液中MMP-2及TIMP-2的表达[J].眼科新进展,2015,35(2):146.[doi:10.13389/j.cnki.rao.2015.0039]
HUANG Liang,LIU Lin-Lin,LUO Yao-Ling,et al. Expression of MMP-2 and TIMP-2 in blood and aqueous humour of patients with primary glaucoma and type 2 diabetes mellitus[J].Recent Advances in Ophthalmology,2015,35(11):146.[doi:10.13389/j.cnki.rao.2015.0039]
[4]仲妍,车慧欣.光学相干断层扫描血管成像（OCTA）在原发性青光眼患者中的检测价值[J].眼科新进展,2018,38(4):352.[doi:10.13389/j.cnki.rao.2018.0082]
ZHONG Yan,CHE Hui-Xin.Detective values of optical coherence tomography angiographyfor primary glaucoma[J].Recent Advances in Ophthalmology,2018,38(11):352.[doi:10.13389/j.cnki.rao.2018.0082]
[5]王玲,樊芳,贾志旸.原发性青光眼生物标志物的研究进展[J].眼科新进展,2022,42(6):495.[doi:10.13389/j.cnki.rao.2022.0101]
WANG Ling,FAN Fang,JIA Zhiyang.Advances in the study of biomarkers of primary glaucoma[J].Recent Advances in Ophthalmology,2022,42(11):495.[doi:10.13389/j.cnki.rao.2022.0101]
[6]杨稀瑞,王继雪,袁星星,等.基于GEO数据库和网络药理学探讨柴胡-葛根治疗原发性青光眼的机制[J].眼科新进展,2022,42(8):603.[doi:10.13389/j.cnki.rao.2022.0123]
YANG Xirui,WANG Jixue,YUAN Xingxing,et al.Mechanism of radix bupleuri and puerariae in the treatment of primary glaucoma based on GEO database and network pharmacology[J].Recent Advances in Ophthalmology,2022,42(11):603.[doi:10.13389/j.cnki.rao.2022.0123]